- TELA Bio to Announce First Quarter 2024 Financial Results
- TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
- TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
- TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
- TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
- TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
- TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
- TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- TELA Bio to Take Part in Connecting the Dots
- TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
More ▼
Key statistics
On Thursday, TELA Bio Inc (TELA:NMQ) closed at 4.39, 3.66% above its 52-week low of 4.23, set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.36 |
---|---|
High | 4.44 |
Low | 4.30 |
Bid | 1.77 |
Offer | 4.98 |
Previous close | 4.45 |
Average volume | 232.67k |
---|---|
Shares outstanding | 24.65m |
Free float | 23.00m |
P/E (TTM) | -- |
Market cap | 108.23m USD |
EPS (TTM) | -2.06 USD |
Data delayed at least 15 minutes, as of Apr 25 2024 21:00 BST.
More ▼